As travelers in the United States prepare for another year of record-setting Dengue fever outbreaks, a human monoclonal antibody (mAb) candidate from a Bethesda, MD-based company may soon obtain U.S. FDA approval.
As of February 12, 2025, the National Institutes of Health and AbViro LLC phase IIa clinical trial is exposing healthy volunteers in Maryland and Vermont to a weakened strain of the Dengue virus. The study will compare three AV-1 dose levels in adults challenged with DENV-3, the most infectious Dengue virus strain.
Will Dengue Passive Immunization Become Available in the USA
Traveling Abroad During Ramadan is Rewarding
The British Islamic Medical Association (BIMA) says Ramadan is a holy month for Muslims, with many 'Brits' traveling abroad to visit friends and family.
This year, the MBIMA says the holy month is expected to begin on February 28, 2025, as the official start of Ramadan follows the lunar calendar, so it depends on the sighting of the moon.
In 2024, 30 million pilgrims performed Umrah during Ramadan, the Islamic pilgrimage in Saudi Arabia. Approximately 13.5 million pilgrims were international travelers, including United Kingdom residents.
In 2023, 1.4 Percent of U.S. Children Ever Experienced Post-COVID Condition
Activity limitation seen in 80 percent of children currently experiencing post-COVID condition
Federal Judge Rules FDA, CDC Must Restore Health Websites Removed Under Trump Order
By India Edwards HealthDay ReporterWEDNESDAY, Feb. 12, 2025 (HealthDay News) — A federal judge has ordered the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration …